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Deﬁciency of the extracellular matrix protein tenascin-X (TNX) was recently described as the molecular basis of a
new, recessive type of Ehlers–Danlos syndrome. Here we report gross abnormalities of the elastic ﬁbers and
microﬁbrils in the dermis of these patients, and reduced dermal collagen content, as determined by quantitative
image analysis. The ascending, ﬁne elastic ﬁbers in the papillary dermis were absent or inconspicuous and had few
branches. The coarse elastic ﬁbers of the reticular dermis were fragmented and clumped. At the ultrastructural
level, irregular and immature elastin ﬁbers and ﬁbers devoid of microﬁbrils were observed. In TNX-deﬁcient
patients the dermal collagen density was reduced, but no structural abnormalities in the collagen ﬁbrils were
found. These ﬁndings suggest that both elastic ﬁber abnormalities and reduced collagen content contribute to the
observed phenotype in TNX-deﬁcient patients.
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The Ehlers–Danlos syndrome (EDS) is a clinically and
genetically heterogeneous connective tissue disorder, char-
acterized by hyperextensibility of the skin, hypermobile
joints, and tissue fragility (Beighton et al, 1998). The
recognition of ultrastructural abnormalities of the collagen
fibrils and the subsequent identification of mutations in
genes encoding collagen and collagen-modifying enzymes
has led to the concept that EDS is a disorder of fibrillar
collagen (Byers, 1994; Hausser and Anton-Lamprecht,
1994). This paradigm was recently challenged by the finding
that deficiency for the extracellular matrix protein tenascin-
X (TNX) causes a clinically distinct, recessive form of EDS
(Burch et al, 1997; Schalkwijk et al, 2001).
The tenascins are a family of large matricellular glycopro-
teins, which all share a similar modular structure consisting of
an N-terminal domain possibly responsible for oligomerization,
a series of EGF-like repeats, a variable number of fibronectin
type III domains and an C-terminal fibrinogen-like domain. To
date three members have been identified in mammals:
tenascin-C, tenascin-R, and TNX (Erickson, 1993; Chiquet
Ehrismann et al, 1994; Minet et al, 1999; Jones and Jones,
2000). TNX, the largest member of the tenascin family, is widely
expressed during embryonic development and in several
connective tissues of the adult, including tendon sheats,
muscle, blood vessels, and throughout the entire dermis
(Bristow et al, 1993; Burch et al, 1995; Geffrotin et al, 1995).
This expression pattern coincides with the connective tissue
defects found in TNX-deficient patients and indicates a pivotal
role for TNX in maintaining the integrity of connective tissues.
Although the association of TNX-deficiency with EDS
suggested one of the first functions for any of the tenascin
family members, the exact pathophysiological mechanism
resulting in this phenotype was hitherto unknown. Previous
studies of the skin of a TNX-deficient EDS patient showed
normal secretion of type I and type V collagens, and
ultrastructural analysis did not reveal gross abnormalities of
the collagen fibrils (Burch et al, 1997; Mao and Bristow,
2001). Histopathological examination of skin biopsies from
five TNX-deficient probands suggested reduced staining of
the dermal connective tissue (Schalkwijk et al, 2001), and a
recent study in TNX null mice also demonstrated a reduced
collagen content in the skin (Mao et al, 2002). Whereas
fibrillar collagens provide the connective tissue with tensile
strength, the elastic fiber system is another major structural
matrix component, providing elasticity and resilience to
connective tissues. The mature elastic fiber is largely
composed of two distinct components: amorphous elastin
and microfibrils. Elastogenesis is thought to begin with the
deposition of microfibrillar components, which form a
scaffold for the alignment of tropoelastin (Mecham, 1991;
Debelle and Tamburro, 1999). Perturbation of the elastic
fibers can occur at any step of this multi-phase process
(Holbrook and Byers, 1989; Christiano and Uitto, 1994). As
the biomechanical properties of the tissues that were
affected in our TNX-deficient patients (skin, joints, small
blood vessels) are not only determined by fibrillar collagen
but also by elastic fibers, TNX could very well be involved in
development and maintenance of the elastic fiber system.
In this study we describe gross abnormalities of the elastic
fibers and microfibrils in the skin of TNX-deficient EDS
patients.
Abbreviations: EDS, Ehlers–Danlos syndrome; FITC, fluorescein
iso-thiocyanate; TNX, tenascin-X
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Results
Histopathology and immunohistochemistry Histopathol-
ogy and immunolocalization of connective tissue compo-
nents were studied in the papillary and reticular dermis of
biopsies from five TNX-deficient probands, and compared
with biopsies from healthy individuals. H&E staining of the
skin biopsies from TNX-deficient patients did not reveal
gross abnormalities. No deviations in epidermal or dermal
thickness were noted. Elastin-van Gieson staining of the
skin biopsies from healthy individuals revealed the normal
pattern of thin elastic fibers oriented perpendicular to the
dermo-epidermal junction, and coarse elastic fibers in the
reticular dermis that were arranged more or less parallel to
the dermo-epidermal junction (Fig 1A). The dermis of all five
TNX-deficient EDS patients showed aberrant elastic fibers.
Figure 1
van Gieson’s staining of elastic fibers in human skin biopsies. In normal non-sun exposed skin, Elastin-van Gieson’s staining shows a typical
candelabra-like pattern oriented perpendicular towards the basal lamina (A). In TNX-deficient patients (B, C), the candelabra-like structure is grossly
disturbed. Note the short, sparsely branched structures in b and the horizontally oriented, coarse fragments and in c fragmentation of elastic fibers in
TNX-deficient skin. Morphometric analysis of five patients and eight controls showed a significant reduction in length of the elastic fibers (po0.01)
(D), number of branches per elastic fiber (po0.01) (E) and relative collagen density (po0.05) (F) in TNX-deficient dermis. Asterisks denote values
significantly different from control (po0.05, po0.01). Scale bar¼50 mm.
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In the reticular dermis, normal looking, slender elastic fibers
were present together with fragmented and clumped
fibers. In the papillary dermis, the number of elastic fibers
was low, fibers were not arranged perpendicular to the
dermal–epidermal junction and elastic fibers appeared
highly fragmented (Fig 1B and C). The elastic fibers
appeared normal around blood vessels in the dermis.
Morphometrical analysis of the elastic fibers on Elastin-
van Gieson stained sections showed a significant decrease
in elastic fiber length in TNX-deficient EDS patients as
compared with age-matched, healthy individuals (po0.01;
Fig 1D). Elastic fiber length was reduced from approxi-
mately 50 mm in the normal skin, to 20 mm in the TNX-
deficient skin. Moreover, the number of branches per elastic
fiber was also considerably decreased (po0.01; Fig 1E).
The length and number of branches of the elastic fibers did
not correlate with the age of the patients or healthy
individuals (not shown).
The relative collagen density in the papillary dermis was
quantified by image analysis in Elastin-van Gieson stained
sections of patients and matched controls. As shown in Fig
1F, the relative collagen density in the papillary dermis was
significantly lower in TNX-deficient patients (po0.05;
Fig 1F). In addition to collagen, we studied the presence
of glycosaminoglycans, which represent another major
constituent of the dermal extracellular matrix. Safranin-O
staining, which detects negatively charged polysacchar-
ides, did not reveal differences between the TNX-deficient
and normal skin (Fig 2A and B). Using immunohistochem-
istry, we analyzed the distribution of decorin, an abundant
dermal proteoglycan that colocalizes and binds to TNX
(Elefteriou et al, 2001), and interacts with elastic fiber
components (Reinboth et al, 2002) and collagen (Brown and
Vogel, 1989). Again, no differences were noted between
the normal and TNX-deficient skin (Fig 2C and D). For
Figure 2
Safranin-O histochemistry and decorin immunostaining. Safranin-O
staining shows a similar glycosaminoglycan distribution in control (A)
and TNX-deficient skin (B). Decorin is equally present in control (C) and
TNX-deficient skin (D). TNX is distributed throughout the entire dermis
of control skin (E) and is absent from TNX-deficient skin (F). Scale
bar¼ 25 mm for A–D, 50 mm for E and F.
Figure3
Immunohistochemical staining for elastin and fibrillin-1. Note the
typical structure of thin, ascending elastin-positive fibers in the papillary
dermis (A) and the thicker fibers in the reticular dermis of normal skin
(C). Fibrillin-1 staining shows a similar pattern (E). In the papillary
dermis of the TNX-deficient skin, elastin-positive and fibrillin-positive
fibers are sparse and fragmented (B) and (F). In the reticular dermis,
clumping and fragmentation of elastin-positive structures is observed in
TNX-deficient patients (D). Scale bar¼ 25 mm.
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comparison, TNX was present throughout the entire dermis
of control skin, whereas it was absent from the TNX-
deficient skin (Fig 2E and F).
Immunohistochemical staining of the elastic fiber com-
ponent elastin showed a distribution similar to the Elastin-
van Gieson staining (Fig 3A–D). In addition, the skin
sections were stained for fibrillin-1, which is a component
of both the elastic fibers and the microfibrillar network that
exists independent of the elastic fibers. In healthy indivi-
duals, the staining for fibrillin-1 revealed a dense network of
fine branching fibers in the papillary dermis arranged
perpendicular to the dermal-epidermal junction (Fig 3E). In
the deeper reticular dermis microfibrils colocalize with the
elastic fibers and fibrillin-1 staining showed a distribution
accordingly. Skin biopsies of all five TNX-deficient EDS
patients showed a strongly decreased staining for fibrillin-1.
Few fibrillin-1 positive fibers ascending from the papillary
dermis to the basal membrane of the epidermis were
present (Fig 3F). The reticular dermis contained many small
fragments of fibrillin-positive material as compared with
control biopsies (not shown).
Ultrastructure of elastic ﬁbers TNX-deficient EDS patients
showed a number of elastic fiber abnormalities as compared
with healthy individuals (Fig 4). Irregularly shaped elastic
fibers were present in all TNX-deficient EDS patients
examined. Large amounts of electron-dense elastin were
present, indicative of ‘‘immature’’ elastin, that is, many
microfibrils with relatively little cross-linked elastin. Small
elastic fibers were observed in both the papillary and reticular
dermis in three of four examined TNX-deficient EDS patients.
In addition, we observed debris-like inclusions inside
the elastic fibers. We also observed abnormalities in the
organization of microfibrils. Excessive amounts of microfibrils
were occasionally present with a tangled rather than a linear
orientation relative to the elastic fiber. Furthermore, in many
fibers elastin appeared to be deposited independent of the
microfibrillar scaffold, as hardly any microfibrils were present
in and around the elastic fibers. Beside atypical elastic fibers,
normal elastic fibers were present as well in each patient.
The morphology of fibroblasts was not altered; fibroblasts
showed a well-developed endoplasmic reticulum, indicative
of active protein synthesis.
In vitro production of microﬁbrils The fragmented mor-
phological appearance of the elastic fibers in adult skin
could be the result from breakdown of pre-existing intact
fibers, or alternatively, it could be the result of reduced
synthesis or a faulty assembly process during development.
We therefore used an in vitro model for microfibril assembly
to address this issue. Both fibroblasts of control and TNX-
deficient individuals formed a network of long, branching
fibrillin-1 positive fibers (Fig 5C and D). The control
fibroblasts and fibroblasts of TNX-deficient patients se-
creted comparable amounts of intact 350 kDa fibrillin-1 in
the culture supernatant (Fig 5B). In addition, no proteolytic
fragments of fibrillin-1 were observed. TNX was secreted by
control fibroblasts in low amounts (Fig 5A), and localization
of TNX was mainly intracellular (Fig 5E).
Discussion
We observed disturbed elastic fiber morphology and
reduced collagen density in skin biopsies of TNX-deficient
EDS patients, demonstrating an essential role of TNX in the
formation and/or maintenance of dermal connective tissue
architecture. An obvious interpretation of these findings is
that TNX is involved in regulation of structural integrity
of elastic fibers and microfibrils, and that the absence of
TNX precludes proper biomechanical functioning of these
structures. Since TNX is present early in embryonic
development in different connective tissues (Matsumoto
et al, 1994; Burch et al, 1995), TNX could be involved in the
development of the elastic fibers through direct interaction
with elastic fiber components. TNX contains a number of
different domains, including fibronectin type III domains and
EGF-repeats that might be involved in intermolecular
interactions (Bristow et al, 1993; Erickson, 1993; Jones
and Jones, 2000). TNX could also provide anchorage
of elastic fibers to cells mediated by interaction with the
cell-surface integrin avb3 (Elefteriou et al, 1999), thereby
stabilizing and organizing the elastic fibers, as has been
shown for the microfibrillar component fibrillin-1 (Pfaff et al,
1996; Sakamoto et al, 1996). Deposition and production
of fibrillin-1 by TNX-deficient fibroblasts in vitro was not
altered, therefore it is unlikely that TNX regulates elastic
fiber assembly and stability directly through interaction with
fibrillin-1. No significant correlation was found between the
length and number of branches of the elastic fibers and the
age of the individuals included in this study (age range 32–
56), which makes it less likely that TNX-deficiency results
in increased breakdown of elastic fibers. Moreover, the
phenotype of TNX-deficient patients is already present in
early childhood. Taken together, we speculate that TNX is
essential for collagen and elastin assembly and stability.
Whether TNX is involved in directly guiding extracellular
matrix assembly, or in maintaining tissue homeostasis
remains unclear. TNX knockout mice, which have recently
been generated, will provide a suitable model to study the
elastic fiber pathology in more detail. These mice are fertile
and viable and they recapitulate the skin manifestations of
the TNX-deficient EDS patients (Mao et al, 2002).
The clinical symptoms of TNX-deficiency also include
vascular fragility of the small blood vessels and joint
hypermobility (Schalkwijk et al, 2001). Both blood vessels
and joint structures such as tendons and ligaments contain
TNX, collagen, and elastic fibers. It is not known to what
extent collagen and elastic fibers are affected in these
tissues. It is, however, very likely that similar connective
tissue alterations will be found there, and that they contribute
to disturbance of functional properties. It is not very likely
that TNX-deficiency results in a generalized elastinopathy, as
has been implied for fibulin-5 (Loeys et al, 2002; Nakamura
et al, 2002; Yanagisawa et al, 2002; Markova et al, 2003).
Although one of the TNX-deficient patients has a chronic
obstructive lung disease (Schalkwijk et al, 2001), which is
consistent with loss of elastic fiber structure, no obvious
abnormalities were found in the elastic fibers in the mitral
valve of one of the TNX-deficient patients (not shown).
A previous study reported that the ultrastructure of
collagen fibrils in the TNX-deficient index patient was
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normal (Burch et al, 1997), which is in agreement with our
observations. It should be noted that in most ligaments
and tendons, elastin content is fairly low compared with
collagen. In view of the reduced collagen content found in
the dermis of our patients, and the reduced collagen
deposition reported in TNX-deficient mice (Mao et al,
2002), it is possible that symptoms of joint hypermobility
are, besides elastic fiber abnormalities, mostly a conse-
quence of quantitative or qualitative collagen fibril altera-
tions. Collagen loss in the reticular dermis does not seem to
be compensated for by an increased content of glycosa-
minoglycans. The discrepancy of reduced collagen content
and normal skin thickness could possibly be explained by
edema, which might also explain why skin of TNX-deficient
patients feels velvety to touch. Clearly, the effect of TNX-
deficiency on collagen metabolism and its contribution to
connective tissue pathology requires further study.
Although we cannot exclude the possibility that TNX
affects the stability of the elastic fibers and collagen,
thereby promoting degradation, we favor the interpretation
that TNX acts as an organizer of connective tissue
assembly. The absence of TNX could cause quantitative
and qualitative alterations of the extracellular matrix. Over
the past decade, several causes of heritable diseases of the
elastic fibers have been elucidated, and it has become
apparent that mutations in genes that encode proteins
involved in elastic fiber biology, will also result in elastic fiber
pathology (for review see Handford et al, 2000; Milewicz
et al, 2000). This study establishes a role for TNX in elastic
fiber biology, which could explain at least part of the
phenotype of the TNX-deficient patients.
Materials and Methods
Patients Four-mm full-thickness punch biopsies were taken from
a non-sun exposed area on the buttock from five TNX-deficient
individuals (age range 32–56 y, average 45  8 y), and eight age-
matched healthy volunteers (age range 25–63 y, average 48  12
y), as described previously (Schalkwijk et al, 2001). Informed
consent was obtained, and the study protocol was approved by
the local medical ethical committee. All clinical investigations were
conducted according to Declaration of Helsinki principles.
Fibroblast culture Human fibroblasts from skin biopsies of healthy
donors and TNX-deficient patients were grown in Dulbecco’s
Figure5
Fibrillin-1 and TNX deposition and secretion. Normal fibroblasts
secrete TNX into the medium in contrast to TNX-deficient fibroblasts,
as shown by western blotting (A). No difference is seen in fibrillin-1
secretion into the medium (B), or in deposition of fibrillin-1 in the
extracellular matrix by control fibroblasts (C) and TNX-deficient
fibroblasts (D). Staining of TNX shows intracellular localization in
normal fibroblasts (E) and absence of staining in TNX-deficient
fibroblasts (F). Scale bar¼25 mm.
Figure 4
Ultrastructural analysis of elastic fibers in dermis. TNX-deficient
skin (A–E) shows many abnormalities in elastic fibers. (A) Fragmented
appearing elastic fiber. (B) The elastin matrix appears to be deposited
independent of the microfibrillar scaffold. Note the absence of
microfibrils within the amorphous elastin and the holes containing
microfibrillar material inside the elastic fiber. (C) Note the blebs of
amorphous elastin without microfibrils as indicated by arrows. (D)
Excessive amounts of elastin containing electron-dense debris. (E)
Microfibrils are excessive and appear to be tangled in TNX-deficient
patients. (F) Elastic fiber in skin from age-matched control. Arrows:
abnormalities of elastic fibers; arrowheads: debris of microfibrils;
asterisk: normal appearing elastic fiber. Scale bar; A–D, F¼0.4 mm,
E¼ 0.17 mm.
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Modified Eagle Medium (DMEM) (Biowhittaker Europe, Verviers,
Belgium) supplemented with 10% fetal calf serum (Seralab,
Nistelrode, The Netherlands) and penicillin/streptomycin (Gibco-
BRL, Life Technologies, Breda, The Netherlands). Fibroblasts were
allowed to attach and spread for at least 3 d and cultures were
maintained at 371C in an 8% CO2 atmosphere. When the
fibroblasts were grown to confluency, they were allowed to grow
for an additional 2 wk to induce formation of microfibrillar
structures.
Immunohistochemistry Biopsies were fixed for 4 h in buffered
4% formalin and embedded in paraffin. Six-micrometer sections
were mounted on 3-aminopropyltriethoxy-silane (Sigma, St Louis,
Missouri)-coated slides and subsequently deparaffinized and
rehydrated. For general histopathology, the sections were stained
with haematoxylin and eosin (H&E). Sections to be stained for
elastin were pre-treated with 2% trypsin for 15 min at 371C. For
immunohistochemical detection of fibrillin-1 no pre-treatment was
required. Sections were blocked with 20% normal goat serum or
20% normal swine serum (Vector Laboratories Inc., Burlingham,
California) before application of primary antibodies. Sections were
subsequently labeled with primary antibodies: monoclonal anti-
elastin (BA-4, Sigma), monoclonal anti-fibrillin-1 (MAB2502; Che-
micon, Temecula, California), or anti-decorin (Steijlen et al, 1994).
Then, sections were washed and incubated with biotinylated
secondary antibody followed by a complex of avidine and
biotinylated horseradish peroxidase according to the manufac-
turer’s instructions (Vector Labs). Aminoethylcarbazol was used as
the chromogenic substrate (Vector Labs) and, if necessary,
sections were counterstained with Mayer’s haematoxylin (Sigma).
Cryo-sections of skin-biopsy specimens were immunostained
for TNX as described before (Schalkwijk et al, 2001). For gene-
ral staining of elastic fibers, Elastin-van Gieson staining was
performed according to standard procedures (Vacca LL: Labora-
tory Manual of Histochemistry. New York: Raven Press, 1985). For
general staining of glycosaminoglycans, Safranin-O staining was
used, according to standard procedures.
For immunohistological studies of fibroblast cultures, cells were
cultured on glass coverslips and fixed in cold 100% methanol. The
fibroblasts were then pre-incubated with 20% normal goat serum,
followed by incubation with monoclonal anti-fibrillin (MAB2502,
Chemicon) or anti-TNX (Schalkwijk et al, 2001). After washing,
FITC-conjugated secondary antibody was added for fibrillin-1
visualization. Glass coverslips were mounted with a glycerol/
phosphate-buffered saline solution, then viewed with a fluores-
cence microscope (Leica, Leica Microsystems, Wetzlar, Germany),
equipped with a digital camera. For TNX staining, secondary anti-
guinea pig biotinylated IgG antibody was added, followed by
avidin–biotin complex antibody (Vector Labs) and visualization with
diaminobenzoyl (DAKO, Carpinteria, California).
Electron microscopy Skin biopsies from four patients were pre-
fixed with 3% glutaraldehyde in 0.1 M sodium cacodylate buffer for
4 h at room temperature. Subsequently, the tissues were rinsed
in the same buffer and post-fixed in 1% osmium tetroxide. The
specimens were dehydrated in an ascending series of alcohol and
embedded in Epon 812 (Merck, Darmstadt, Germany). Semi-thin
toluidine blue-stained sections were examined to select the
papillary and superficial reticular dermis as well as the deep
reticular dermis. Ultrathin sections were cut on a Reichert OM U2
ultramicrotome (Leica, Vienna, Austria) and double contrasted with
2% uranyl acetate and 0.1% lead citrate. The sections were
examined with a Jeol 1010 electron microscope (JEOL Ltd., Tokyo,
Japan).
Image analysis and morphometry Images of Elastin-van Gieson
stained sections were acquired using a Zeiss Axioskop micro-
scope (Carl Zeiss, Go¨ttingen, Germany) equipped with a Sony
DXC-390P 3CCD digital camera (Sony, Tokyo, Japan). Three
concurrent sections of each individual were used for morphometric
analysis. Length of elastic fibers was analyzed semi-automatically
using IPLab software (Scananalytics, Fairfax) and number of
branches was counted manually. Relative density of collagen
was determined on Elastin-van Gieson stained sections using
ImagePro Plus software (Media Cybernetics, Silver Spring, Mary-
land). This was accomplished by determining the percentage of
unstained area in the papillary dermis in the region of interest. The
area of interest was consistently set just below the epidermis
across the entire distance of the biopsy, with a depth of 0.3 mm. All
measurements were performed at  200 magnification.
Statistical procedures Student’s t test was used for comparison
of means between groups. A value of po0.05 was considered
significant.
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